Download PDF
Semin Reprod Med 2001; 19(1): 037-048
DOI: 10.1055/s-2001-13909
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

On the Role of Human Chorionic Gonadotropin (hCG) in the Embryo-Endometrial Microenvironment: Implications for Differentiation and Implantation

P. Licht, V. Russu, L. Wildt
  • Department of Obstetrics and Gynecology, Division of Gynecological Endocrinology and Reproductive Medicine, University of Erlangen-Nürnberg, Erlangen, Germany
Further Information

Publication History

Publication Date:
31 December 2001 (online)

    Permissions and Reprints

ABSTRACT

Recent evidence suggests that human chorionic gonadotropin (hCG), in addition to its well-known endocrine effects on the corpus luteum, may act as a growth and differentiation factor during pregnancy. According to experimental results, its mode of action may be divided into three sequential phases. During the first phase, which begins at the blastocyst stage and lasts until the occurrence in the serum, hCG acts preferentially in a juxtacrine manner. We have used an intrauterine microdialysis system developed in our laboratory to administer low concentrations of hCG to the endometrium of women in the luteal phase of the menstrual cycle. HCG administration provoked profound effects on paracrine parameters of differentiation (IGFBP-1, prolactin) and implantation (LIF, M-CSF). VEGF, a cytokine important for neoangiogenesis, was significantly stimulated by hCG (P <.01), suggesting a role for hCG in the control of endometrial vascularization and placentation. The investigation of endometrial parameters of tissue remodeling revealed a significant increase of MMP-9 (P <.05) but not of TIMP-1 following hCG infusion. The second, endocrine, phase of hCG action is marked by the appearance of hCG in the maternal serum. Rising systemic hCG levels cause a very rapid elevation of serum progesterone reflecting the rescue of the corpus luteum. Other endocrine functions of hCG include its intrinsic thyrotropic activity as well as modulation of fetal testicular, ovarian, and adrenal function. The third phase may be characterized by the expression of full-length hCG/LH receptors on the trophoblasts themselves. Before the ninth week of gestation, human villous trophoblasts express a truncated hCG/LH receptor isoform (50 kDa) and are probably not responsive to hCG. Later, the expression pattern is switched to the full-length receptor (80 kDa), allowing hCG also to modulate the differentiation of the trophoblasts themselves. A special feature is the self-regulation of hCG biosynthesis that may in part explain the unique secretion profile of the hormone with peak levels during the first trimester followed by a rapid decline after the tenth week of gestation. In summary, hCG seems to have a variety of local and systemic functions in and outside the embryo-endometrial microenvironment.

KEYWORD

Gonadotropin - hCG - intrauterine microdialysis - cytokines - endometrial receptivity - trophoblast differentiation

REFERENCES

  • 1 Wilcox A J, Baird D D, Weinberg C R. Time of implantation of the conceptus and loss of pregnancy.  N Engl J Med . 1999;  340 1796-1799
    CrossrefPubMedGoogle Scholar
  • 2 Braude P, Pelham H, Flach G, Lobatto R. Post-transcriptional control in the early mouse embryo.  Nature . 1979;  282 102-105
    PubMedGoogle Scholar
  • 3 Mark M, Rijli F M, Chambon P. Homeobox genes in embryogenesis and pathogenesis.  Pediatr Res . 1997;  42 421-429
    PubMedGoogle Scholar
  • 4 Stewart C L, Kaspar P, Brunet L J. Blastocyst implantation depends on maternal expression of leukemia inhibitory factor.  Nature . 1992;  359 76-79
    CrossrefPubMedGoogle Scholar
  • 5 Satokata I, Benson G, Maas R. Sexually dimorphic sterility phenotypes in Hoxa-10-deficient mice.  Nature . 1995;  374 460-463
    CrossrefPubMedGoogle Scholar
  • 6 Robb L, Li R, Hartley L, Nandurkar H H, Koentgen F, Begley C G. Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation.  Nat Med . 1998;  4 303-308
    CrossrefPubMedGoogle Scholar
  • 7 Pollard J W, Hunt J S, Wiktor-Jedrzejczak W, Stanley E R. A pregnancy defect in the osteopetrotic (op/op) mouse demonstrates the requirement of CSF-1 in female infertility.  Dev Biol . 1991;  148 273-283
    CrossrefPubMedGoogle Scholar
  • 8 Harvey M B, Leco K J, Arcellana-Panlilie M Y, Zhang X, Edwards D R, Schultz G A. Roles of growth factors during peri-implantation development.  Mol Hum Reprod . 1995;  10 712-718
    PubMedGoogle Scholar
  • 9 Simon C, Frances A, Piquette G N. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist.  Endocrinology . 1994;  134 521-528
    CrossrefPubMedGoogle Scholar
  • 10 Hoshina M, Boothby M, Hussa R, Patillo R, Camel H M, Boime I. Linkage of human chorionic gonadotrophin and placental lactogen biosynthesis to trophoblast differentiation and tumorigenesis.  Placenta . 1985;  6 163-172
    PubMedGoogle Scholar
  • 11 Bonduelle M L, Dodd R, Liebaers I, Van Steirteghem A, Williamson R, Akhurst R. Chorionic gonadotrophin-beta mRNA, a trophoblast marker, is expressed in human 8-cell embryos derived from tripronucleate zygotes.  Hum Reprod . 1988;  3 909-914
    PubMedGoogle Scholar
  • 12 Shi Q J, Lei Z M, Rao C V, Lin J. Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts.  Endocrinology . 1993;  132 1387-1395
    CrossrefPubMedGoogle Scholar
  • 13 Cronier L, Bastide B, Herve J C, Deleze J, Malassine A. Gap junctional communication during human trophoblast differentiation: influence of human chorionic gonadotropin.  Endocrinology . 1994;  135 402-408
    CrossrefPubMedGoogle Scholar
  • 14 Licht P, Cao H, Lei Z M, Rao C V, Merz W E. Novel self-regulation of human chorionic gonadotropin biosynthesis in term pregnancy human placenta.  Endocrinology . 1993;  133 3014-1025
    CrossrefPubMedGoogle Scholar
  • 15 Licht P, Cao H, Zuo J. Lack of self-regulation of human chorionic gonadotropin biosynthesis in human choriocarcinoma cells.  J Clin Endocrinol Metab . 1994;  78 1188-1194
    CrossrefPubMedGoogle Scholar
  • 16 Tao Y X, Lei Z M, Hofmann G E, Rao C V. Human intermediate trophoblasts express human chorionic gonadotropin/ luteinizing hormone receptor gene.  Biol Reprod . 1995;  53 899-904
    PubMedGoogle Scholar
  • 17 Yagel S, Geva T E, Soloman H. High levels of human chorionic gonadotrophin retard first trimester trophoblast invasion in vitro by decreasing urokinase plasminogen activator and collagenase activities.  J Clin Endocrinol Metab . 1993;  77 1506-1511
    CrossrefPubMedGoogle Scholar
  • 18 Zygmunt M, Hahn D, Munstedt K, Bishof P, Lang U. Invasion of cytotrophoblastic JEG-3 cells is stimulated by hCG in vitro.  Placenta . 1998;  19 587-593
    CrossrefPubMedGoogle Scholar
  • 19 Licht P, Wildt L. Gonadal and extragonadal receptors for human chorionic gonadotropin (hCG) and luteinizing hormone (LH).  Ass Reprod Rev . 1998;  8 152-172
    PubMedGoogle Scholar
  • 20 Merz W E, Erlewein C, Licht P, Harbarth P. The secretion of human chorionic gonadotropin as well as the α- and β-messenger ribonucleic acid levels are stimulated by exogenous gonadoliberin pulses applied to first trimester placenta in a superfusion tissue culture system.  J Clin Endocrinol Metab . 1991;  73 84-92
    PubMedGoogle Scholar
  • 21 Licht P, Harbarth P, Merz W E. Evidence for a modulation of human chorionic gonadotropin (hCG) subunit messenger ribonucleic acid levels and hCG secretion by γ-aminobutyric acid (GABA) in human first trimester placenta in vitro.  Endocrinology . 1992;  130 490-496
    CrossrefPubMedGoogle Scholar
  • 22 Benveniste R, Speeg K V, Carpenter G, Cohen S, Lindner J, Rabinowitz D. Epidermal growth factor stimulates secretion of human chorionic gonadotropin by cultured human choriocarcinoma cells.  J Clin Endocrinol Metab . 1978;  46 169-171
    PubMedGoogle Scholar
  • 23 Merz W E. Biosynthesis of human chorionic gonadotropin: a review.  Eur J Endocrinol . 1996;  135 269-284
    PubMedGoogle Scholar
  • 24 Lei Z M, Toth P, Rao C V, Pridham D D. Novel co-expression of human chorionic gonadotropin (hCG)/luteinizing hormone receptors and their ligand hCG in human fallopian tubes.  J Clin Endocrinol Metab . 1993;  77 863-872
    CrossrefPubMedGoogle Scholar
  • 25 Reshef E, Lei Z M, Rao C V, Pridham D D, Chegini N, Luborsky J L. The presence of gonadotropin receptors in non-pregnant human uterus, human placenta, fetal membranes, and decidua.  J Clin Endocrinol Metab . 1990;  70 421-429
    PubMedGoogle Scholar
  • 26 Környei J, Lei Z M, Rao C V. Human myometrial smooth muscle cells are novel targets of direct regulation by human chorionic gonadotropin.  Biol Reprod . 1993;  49 1149-1157
    PubMedGoogle Scholar
  • 27 Ziecik A J, Stanchev P D, Tilton J E. Evidence for the presence of luteinizing hormone/human chorionic gonadotropin binding sites in the porcine uterus.  Endocrinology . 1986;  119 1159-1163
    PubMedGoogle Scholar
  • 28 Jensen J D, Odell W D. Identification of LH/hCG receptors in the rabbit uterus.  Proc Soc Exp Biol Med . 1988;  189 28-30
    PubMedGoogle Scholar
  • 29 Bonnamy P J, Benhaim A, Leymarie P. Estrous-cycle related changes in high affinity luteinizing hormone/human chorionic gonadotropin binding sites in the rat uterus.  Endocrinology . 1990;  126 421-430
    PubMedGoogle Scholar
  • 30 Bonnamy P J, Benhaim A, Leymarie P. Uterine luteinizing hormone/human chorionic gonadotropin binding sites in the early pregnant rat uterus: evidence for a total occupancy in the peri-implantation period.  Endocrinology . 1993;  132 1240-1246
    CrossrefPubMedGoogle Scholar
  • 31 Mukherjee D, Manna P R, Bhattacharya S. Functional relevance of luteinizing hormone receptors in the mouse uterus.  Eur J Endocrinol . 1994;  131 103-108
    PubMedGoogle Scholar
  • 32 Freidman S, Gurevich M, Shemesh M. Bovine cyclic endometrium contains high-affinity luteinizing hormone/ human chorionic gonadotropin binding sites.  Biol Reprod . 1995;  52 1020-1026
    PubMedGoogle Scholar
  • 33 Lin J, Lei Z M, Lojun S, Rao C V, Satjaswaroop P G, Day T G. Increased expression of luteinizing hormone/human chorionic gonadotropin receptor gene in human endometrial carcinomas.  J Clin Endocrinol Metab . 1994;  79 1483-1491
    CrossrefPubMedGoogle Scholar
  • 34 Han S W, Lei Z M, Rao C V. Treatment of human endometrial stroma cells with chorionic gonadotropin promotes their morphological and functional differentiation into decidua.  Mol Cell Endocrinol . 1999;  147 7-16
    CrossrefPubMedGoogle Scholar
  • 35 Han S W, Lei Z M, Rao C V. Up-regulation of cyclooxygenase-2 gene expression by chorionic gonadotropin during the differentiation of human endometrial stromal cells into decidua.  Endocrinology . 1996;  137 1791-1797
    CrossrefPubMedGoogle Scholar
  • 36 Han S W, Lei Z M, Rao C V. Homologous down-regulation of luteinizing hormone/chorionic gonadotropin receptors by increasing the degradation of receptor transcripts in human endometrial stromal cells.  Biol Reprod . 1997;  57 158-164
    PubMedGoogle Scholar
  • 37 Fazleabas A T, Donnelly K M, Srinivasan S, Fortman J D, Miller J B. Modulation of the baboon (Papio anubis) uterine endometrium by chorionic gonadotrophin during the period of uterine receptivity.  Proc Natl Acad Sci U S A . 1999;  96 2543-2548
    CrossrefPubMedGoogle Scholar
  • 38 Licht P, Lösch A, Dittrich R, Neuwinger J, Siebzehnrübl E, Wildt L. Novel insights into human endometrial paracrinology and feto-maternal communication by intrauterine microdialysis.  Hum Reprod Update . 1998;  4 532-538
    CrossrefPubMedGoogle Scholar
  • 39 Irving J A, Lala P K. Functional role of cell surface integrins on human trophoblast cell migration: regulation by a TGF-beta, IGF-II, and IGFBP-1.  Exp Cell Res . 1995;  21 419-427
    PubMedGoogle Scholar
  • 40 Hamilton G S, Lysiak J J, Han V K, Lala P K. Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1.  Exp Cell Res . 1998;  244 147-156
    CrossrefPubMedGoogle Scholar
  • 41 Bishof P, Meisser A, Campana A, Tseng L. Effects of decidua-conditioned medium and insulin-like growth factor binding protein-1 on trophoblastic matrix metalloproteinases and their inhibitors.  Placenta . 1998;  19 457-464
    CrossrefPubMedGoogle Scholar
  • 42 Neulen J, Yan Z, Raczek S. HCG-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells.  J Clin Endocrinol Metab . 1995;  80 1967-1971
    CrossrefPubMedGoogle Scholar
  • 43 Owens O M, Ryan K J, Tulchinsky D. Episodic secretion of human chorionic gonadotropin in early pregnancy.  J Clin Endocrinol Metab . 1981;  53 1307-1309
    PubMedGoogle Scholar
  • 44 Bischof P, Campana A. A model for implantation of the human blastocyst and early placentation.  Hum Reprod Update . 1996;  2 262-270
    CrossrefPubMedGoogle Scholar
  • 45 Tomer Y, Huber G K, Davies T F. Human chorionic gonadotropin (hCG) interacts directly with recombinant human TSH receptors.  J Clin Endocrinol Metab . 1992;  74 1477-1479
    CrossrefPubMedGoogle Scholar
  • 46 Saez J M. Leydig cells: endocrine, paracrine, and autocrine regulation.  Endocrine Rev . 1994;  15 574-626
    CrossrefPubMedGoogle Scholar
  • 47 Lei Z M, Rao C V, Kornyei J, Licht P, Hiatt E S. Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain.  Endocrinology . 1993;  132 2262-2270
    CrossrefPubMedGoogle Scholar
  • 48 Toth P, Lukacs H, Hiatt E S, Reid K H, Iyer V, Rao C V. Administration of human chorionic gonadotropin affects sleep-wake phases and other associated behaviours in cycling female rats.  Brain Res . 1994;  654 181-190
    CrossrefPubMedGoogle Scholar
      >